ArticleHuman gene therapy2025

Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1.

Avani V Mylvara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.